Benzinga's Top Upgrades
March 06, 2014 at 08:22 AM EST
Analysts at BMO Capital upgraded Biogen Idec (NASDAQ: BIIB) from “market perform” to “outperform.” The price target for Biogen Idec has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.